Fundraising Fox테라펙스
1 known investors
Find your way into 테라펙스
Sign up to see every warm intro you have to 테라펙스
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 테라펙스 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Therapex is a drug discovery company developing new therapeutics using in-silico molecular design and in-house medicinal chemistry and pharmacological evaluation systems. It has expertise in PROTAC-based new modalities that degrade disease-causing proteins.
Investors · 1
Frequently asked questions
- What does 테라펙스 do?
- Therapex is a drug discovery company developing new therapeutics using in-silico molecular design and in-house medicinal chemistry and pharmacological evaluation systems. It has expertise in PROTAC-based new modalities that degrade disease-causing proteins.
- Who are 테라펙스's investors?
- 테라펙스's investors include DAYLI Partners.